Additionally, proliferative T cell responses leading to CD28 downregulation are associated with IPF progression, suggesting that assessing circulating CD4 T cells could identify patients prone to deterioration [59]. The gene discussed is CD28; the disease is idiopathic pulmonary fibrosis.